Company / Revenue
bioAffinity Technologies, Inc. Revenue History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$9.4M
FY2025
5-year range
$4.8K / $9.4M
FY2022-FY2025
Trend
+269.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue changed +270% YoY in FY2025, a notable deviation from the 3-year average annual change of +47922%.
Based on SEC 10-K filings.
$9M in FY2025.
Improved from $7M to $9M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue increased 269.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.4M | +269.7% |
| FY2024 | $2.5M | -63.3% |
| FY2023 | $6.9M | +143560.2% |
| FY2022 | $4.8K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026